Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Equity Average: 2021-2024

Historic Equity Average for Oncology Institute (TOI) over the last 4 years, with FY2024 value amounting to $30.3 million.

  • Oncology Institute's Equity Average fell 14757.21% to -$10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.6 million, marking a year-over-year decrease of 14757.21%. This contributed to the annual value of $30.3 million for FY2024, which is 6636.29% down from last year.
  • Oncology Institute's Equity Average amounted to $30.3 million in FY2024, which was down 6636.29% from $90.1 million recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Equity Average peaked at $113.7 million during FY2022, and registered a low of $30.3 million during FY2024.
  • For the 4-year period, Oncology Institute's Equity Average averaged around $75.1 million, with its median value being $78.1 million (2021).
  • As far as peak fluctuations go, Oncology Institute's Equity Average surged by 7188.42% in 2022, and later crashed by 6636.29% in 2024.
  • Oncology Institute's Equity Average (Annual) stood at $66.1 million in 2021, then soared by 71.88% to $113.7 million in 2022, then dropped by 20.73% to $90.1 million in 2023, then tumbled by 66.36% to $30.3 million in 2024.
  • Its last three reported values are $30.3 million in FY2024, $90.1 million for FY2023, and $113.7 million during FY2022.